Co-Diagnostics, Inc. (CODX)

NASDAQ: CODX · IEX Real-Time Price · USD
3.15
-0.09 (-2.78%)
At close: Feb 1, 2023, 4:00 PM
3.30
+0.15 (4.76%)
Pre-market: Feb 2, 2023, 8:18 AM EST
-2.78%
Market Cap 97.39M
Revenue (ttm) 53.22M
Net Income (ttm) 15.17M
Shares Out 30.92M
EPS (ttm) 0.47
PE Ratio 6.70
Forward PE 16.00
Dividend n/a
Ex-Dividend Date n/a
Volume 235,164
Open 3.21
Previous Close 3.24
Day's Range 3.15 - 3.33
52-Week Range 2.26 - 7.35
Beta -0.53
Analysts Buy
Price Target 11.90 (+277.78%)
Earnings Date Mar 22, 2023

About CODX

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 12, 2017
Employees 101
Stock Exchange NASDAQ
Ticker Symbol CODX
Full Company Profile

Financial Performance

In 2021, Co-Diagnostics's revenue was $97.89 million, an increase of 31.30% compared to the previous year's $74.55 million. Earnings were $36.66 million, a decrease of -13.70%.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for CODX stock is "Buy." The 12-month stock price forecast is $11.9, which is an increase of 277.78% from the latest price.

Price Target
$11.9
(277.78% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test Design

Designed using the Company's proprietary platform, initial test design remains effective detection tool even after three years of variants and more than 33 million sold worldwide; Company also announc...

1 week ago - PRNewsWire

Co-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022

SALT LAKE CITY , Nov. 30, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development o...

2 months ago - PRNewsWire

Co-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, Germany

SALT LAKE CITY , Nov. 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development o...

2 months ago - PRNewsWire

CoDiagnostics, Inc. (CODX) Reports Q3 Loss, Lags Revenue Estimates

CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of 33.33% and 24.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock...

2 months ago - Zacks Investment Research

Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nearing commencement of clinical evaluations for the Co-Dx PCR Home platform COVID-19 test volumes continue to impact third quarter results SALT LAKE CITY , Nov. 10, 2022 /PRNewswire/ -- Co-Diagnostic...

2 months ago - PRNewsWire

Co-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZ

SALT LAKE CITY , Nov. 3, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of...

3 months ago - PRNewsWire

Co-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific Officer

SALT LAKE CITY , Nov. 1, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of m...

3 months ago - PRNewsWire

CO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCAST

SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, ...

3 months ago - PRNewsWire

Co-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South Africa

SALT LAKE CITY , Oct. 26, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development o...

3 months ago - PRNewsWire

Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand

SALT LAKE CITY , Oct. 19, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development o...

3 months ago - PRNewsWire

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 17, 2022 - (NASDAQ: CODX)

NEW YORK , Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Co-Diagnostics, Inc.. Shareholders who purchased shares of CODX during the class period liste...

3 months ago - PRNewsWire

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Co-Diagnostics (CODX) Investors of Today's Lead Plaintiff Deadline in Securities Class Action

San Francisco, California--(Newsfile Corp. - October 17, 2022) - Hagens Berman urges Co-Diagnostics, Inc. (NASDAQ: CODX) investors who suffered significant losses to submit your losses now. Class Peri...

3 months ago - Newsfile Corp

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - October 17, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Co-Diagnostics, I...

3 months ago - Newsfile Corp

Co-Dx Class Action: Levi & Korsinsky Reminds Co-Diagnostics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 17, 2022 - CODX

New York, New York--(Newsfile Corp. - October 16, 2022) - Levi & Korsinsky, LLP notifies investors in Co-Diagnostics, Inc. ("Co-Dx" or the "Company") (NASDAQ: CODX) of a class action securities lawsui...

3 months ago - Newsfile Corp

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline - CODX

New York, New York--(Newsfile Corp. - October 16, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx" or the "Company") and ...

3 months ago - Newsfile Corp

CODX FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX

NEW YORK , Oct. 14, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Co-Diagnostics, Inc. (NASDAQ: CODX) between May 12, 2022 and Au...

3 months ago - PRNewsWire

CODX SHAREHOLDER ALERT: Jakubowitz Law Reminds Co-Dx Shareholders of a Lead Plaintiff Deadline of October 17, 2022

NEW YORK , Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Co-Diagnostics, Inc. (NASDAQ: CODX). To receiv...

3 months ago - PRNewsWire

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Co-Diagnostics, Inc. (CODX) and Encourages Long-Term CODX Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Co-Diagnostics, Inc. (“Co-Diagnostics” or the Company) (NASDAQ: CODX) on behalf of the Company's long-term investors.

3 months ago - Business Wire

CODX Deadline Notice: ROSEN, Leading Investor Counsel, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX

New York, New York--(Newsfile Corp. - October 11, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Co-Diagnostics, Inc. (NASDAQ: CODX) between Ma...

4 months ago - Newsfile Corp

CODX Final Notice: ROSEN, Top Ranked Investor Counsel, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX

New York, New York--(Newsfile Corp. - October 9, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Co-Diagnostics, Inc. (NASDAQ: CODX) between May...

4 months ago - Newsfile Corp

CODX LAWSUIT ALERT: Levi & Korsinsky Notifies Co-Diagnostics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , Oct. 6, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Co-Diagnostics, Inc. ("Co-Dx" or the "Company") (NASDAQ: CODX) of a class action securities lawsuit. CLASS DEFINITIO...

4 months ago - PRNewsWire

CODX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 17, 2022 in the Class Action Filed on Behalf of Co-Diagnostics, Inc. Shareholders

NEW YORK , Oct. 4, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Co-Diagnostics, Inc. (NASDAQ: CODX) alleging that the Com...

4 months ago - PRNewsWire

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Co-Dx Investors of a Lead Plaintiff Deadline of October 17, 2022

NEW YORK , Oct. 3, 2022 /PRNewswire/ -- Attention Co-Diagnostics, Inc. ("Co-Dx") (NASDAQ: CODX) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on beha...

4 months ago - PRNewsWire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX

New York, New York--(Newsfile Corp. - October 1, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Co-Diagnostics, Inc. (NASDAQ: CODX) between May...

4 months ago - Newsfile Corp

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm's Attorneys, Securities Class Action Pending

San Francisco, California--(Newsfile Corp. - September 30, 2022) - Hagens Berman urges Co-Diagnostics, Inc. (NASDAQ: CODX) investors who suffered significant losses to submit your losses now.Class Per...

4 months ago - Newsfile Corp